{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:58:52Z","timestamp":1788476332941,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10072-021-05562-y","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T13:05:06Z","timestamp":1629205506000},"page":"1929-1938","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ten years evaluation of epidemiology- and mortality-related factors in adults and children with Guillain-Barr\u00e9 syndrome in the north of Iran"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-0654","authenticated-orcid":false,"given":"Mozaffar","family":"Hosseininezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-4564","authenticated-orcid":false,"given":"Seyed Sepehr","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-3087","authenticated-orcid":false,"given":"Sajjad","family":"Saadat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0110-2987","authenticated-orcid":false,"given":"Mona","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-1846","authenticated-orcid":false,"given":"Hoora","family":"Ghovvati Choshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4925-9163","authenticated-orcid":false,"given":"Alireza","family":"Hooshmand Marvasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Gholipour Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"issue":"2","key":"5562_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1734-1140(10)70261-9","volume":"62","author":"AB Pithadia","year":"2010","unstructured":"Pithadia AB, Kakadia N (2010) Guillain-Barr\u00e9 syndrome (GBS). Pharmacol Rep 62(2):220\u2013232","journal-title":"Pharmacol Rep"},{"issue":"4","key":"5562_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jns.12239","volume":"22","author":"JO Sipil\u00e4","year":"2017","unstructured":"Sipil\u00e4 JO et al (2017) Epidemiology of Guillain-Barr\u00e9 syndrome in Finland 2004\u20132014. J Peripher Nerv Syst 22(4):440\u2013445","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"5562_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.pepo.2013.02.006","volume":"88","author":"AS El-Beleidy","year":"2013","unstructured":"El-Beleidy AS et al (2013) Antiganglioside antibodies determine the clinical severity and predict response to therapy in Egyptian children with Guillain-Barr\u00e9 Syndrome. Pediatr Pol 88(3):224\u2013229","journal-title":"Pediatr Pol"},{"issue":"2","key":"5562_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jns.12209","volume":"22","author":"BC Jacobs","year":"2017","unstructured":"Jacobs BC et al (2017) International Guillain-Barr\u00e9 Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst 22(2):68\u201376","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"5562_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000438752","volume":"45","author":"MD Benedetti","year":"2015","unstructured":"Benedetti MD et al (2015) A multicentric prospective incidence study of Guillain-Barr\u00e9 syndrome in Italy. the ITANG study. Neuroepidemiology 45(2):90\u201399","journal-title":"Neuroepidemiology"},{"issue":"3","key":"5562_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000480693","volume":"2","author":"AA Momen","year":"2017","unstructured":"Momen AA, Shakurnia A (2017) The epidemiology of guillain-barr\u00e9 syndrome in children under 15 years old in Southwest Iran. Biomed Hub 2(3):1\u20138","journal-title":"Biomed Hub"},{"issue":"9","key":"5562_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1473-3099(13)70104-X","volume":"13","author":"JC Kwong","year":"2013","unstructured":"Kwong JC et al (2013) Risk of Guillain-Barr\u00e9 syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 13(9):769\u2013776","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5562_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/tmi.13181","volume":"24","author":"VK Wachira","year":"2019","unstructured":"Wachira VK, Peixoto HM, de Oliveira MRF (2019) Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007\u20132017: what has changed? Tropical Med Int Health 24(2):132\u2013142","journal-title":"Tropical Med Int Health"},{"issue":"4","key":"5562_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","volume":"48","author":"K Ogawara","year":"2000","unstructured":"Ogawara K et al (2000) Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48(4):624\u2013631","journal-title":"Ann Neurol"},{"issue":"7","key":"5562_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.je.2016.07.003","volume":"27","author":"S Kobori","year":"2017","unstructured":"Kobori S et al (2017) Coexisting infectious diseases on admission as a risk factor for mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome. J Epidemiol 27(7):311\u2013316","journal-title":"J Epidemiol"},{"issue":"16","key":"5562_CR11","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","volume":"375","author":"B Parra","year":"2016","unstructured":"Parra B et al (2016) Guillain-Barr\u00e9 syndrome associated with Zika virus infection in Colombia. N Engl J Med 375(16):1513\u20131523","journal-title":"N Engl J Med"},{"issue":"20","key":"5562_CR12","doi-asserted-by":"publisher","first-page":"e2168","DOI":"10.1212\/WNL.0000000000009180","volume":"94","author":"C Grave","year":"2020","unstructured":"Grave C et al (2020) Seasonal influenza vaccine and Guillain-Barr\u00e9 syndrome: a self-controlled case series study. Neurology 94(20):e2168\u2013e2179","journal-title":"Neurology"},{"issue":"3","key":"5562_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10072-019-04163-0","volume":"41","author":"F Racca","year":"2020","unstructured":"Racca F et al (2020) Practical approach to respiratory emergencies in neurological diseases. Neurol Sci 41(3):497\u2013508","journal-title":"Neurol Sci"},{"key":"5562_CR14","doi-asserted-by":"crossref","unstructured":"Wijdicks EF, Klein CJ (2017) Guillain-barr\u00e9 syndrome. In Mayo clinic proceedings, vol 92,\u00a0 No. 3. Elsevier, pp 467\u2013479","DOI":"10.1016\/j.mayocp.2016.12.002"},{"key":"5562_CR15","doi-asserted-by":"publisher","unstructured":"Hughes RA, Swan AV, van Doorn PA (2014) Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochr Database Syst Rev\u00a02014(9):CD002063. https:\/\/doi.org\/10.1002\/14651858.CD002063.pub6","DOI":"10.1002\/14651858.CD002063.pub6"},{"issue":"2","key":"5562_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10072-019-04063-3","volume":"41","author":"C Li","year":"2020","unstructured":"Li C et al (2020) The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barr\u00e9 syndrome. Neurol Sci 41(2):295\u2013303","journal-title":"Neurol Sci"},{"issue":"1","key":"5562_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5144\/0256-4947.2006.22","volume":"26","author":"MA Arami","year":"2006","unstructured":"Arami MA, Yazdchi M, Khandaghi R (2006) Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Ann Saudi Med 26(1):22\u201327","journal-title":"Ann Saudi Med"},{"issue":"9","key":"5562_CR18","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jocn.2013.11.041","volume":"21","author":"S Yadegari","year":"2014","unstructured":"Yadegari S, Kazemi N, Nafissi S (2014) Clinical and electrophysiological features of Guillain-Barr\u00e9 syndrome in Iran. J Clin Neurosci 21(9):1554\u20131557","journal-title":"J Clin Neurosci"},{"issue":"18","key":"5562_CR19","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","volume":"70","author":"A Alshekhlee","year":"2008","unstructured":"Alshekhlee A et al (2008) Guillain-Barr\u00e9 syndrome: incidence and mortality rates in US hospitals. Neurology 70(18):1608\u20131613","journal-title":"Neurology"},{"issue":"11","key":"5562_CR20","first-page":"493","volume":"55","author":"MY Yakoob","year":"2005","unstructured":"Yakoob MY et al (2005) Characteristics of patients with Guillain Barre Syndrome at a tertiary care centre in Pakistan, 1995\u20132003. J Pak Med Assoc 55(11):493","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"5562_CR21","first-page":"280","volume":"43","author":"SD Said","year":"2009","unstructured":"Said SD (2009) Clinical experience with Gullain Barre syndrome over a 6-year period in one hospital in the Middle East. Jordan Med J 43(4):280\u2013285","journal-title":"Jordan Med J"},{"issue":"2","key":"5562_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-0404.1987.tb07901.x","volume":"75","author":"K Radhakrishnan","year":"1987","unstructured":"Radhakrishnan K, El-Mangoush M, Gerryo S (1987) Descriptive epidemiology of selected neuromuscular disorders in Benghazi, Libya. Acta Neurol Scand 75(2):95\u2013100","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"5562_CR23","first-page":"71","volume":"56","author":"F B\u00f6l\u00fckba\u015fi","year":"2019","unstructured":"B\u00f6l\u00fckba\u015fi F et al (2019) Guillain-barr\u00e9 syndrome and its variants: Clinical course and prognostic factors. Arch Neuropsychiatry 56(1):71","journal-title":"Arch Neuropsychiatry"},{"issue":"1\u20132","key":"5562_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jns.2014.05.065","volume":"343","author":"HT Benamer","year":"2014","unstructured":"Benamer HT, Bredan A (2014) Guillain-Barr\u00e9 syndrome in Arab countries: a systematic review. J Neurol Sci 343(1\u20132):221\u2013223","journal-title":"J Neurol Sci"},{"issue":"3","key":"5562_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10072-018-3688-4","volume":"40","author":"E Granieri","year":"2019","unstructured":"Granieri E et al (2019) Incidence study of Guillain-Barr\u00e9 syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up. Neurol Sci 40(3):603\u2013609","journal-title":"Neurol Sci"},{"issue":"2","key":"5562_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s00415-018-9151-x","volume":"266","author":"H Al-Hakem","year":"2019","unstructured":"Al-Hakem H et al (2019) Guillain-Barr\u00e9 syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity. J Neurol 266(2):440\u2013449","journal-title":"J Neurol"},{"issue":"6 Part 2","key":"5562_CR27","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1016\/j.lpm.2013.02.328","volume":"42","author":"PA van Doorn","year":"2013","unstructured":"van Doorn PA (2013) Diagnosis, treatment and prognosis of Guillain-Barr\u00e9 syndrome (GBS). La Presse M\u00e9dicale 42(6 Part 2):e193\u2013e201","journal-title":"La Presse M\u00e9dicale"},{"issue":"4","key":"5562_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.7861\/clinmedicine.10-4-399","volume":"10","author":"J Pritchard","year":"2010","unstructured":"Pritchard J (2010) Guillain-Barr\u00e9 syndrome. Clin Med (Lond) 10(4):399\u2013401","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"5562_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s10072-010-0434-y","volume":"32","author":"F Incecik","year":"2011","unstructured":"Incecik F, Herg\u00fcner MO, Altunbasak S (2011) Guillain-Barr\u00e9 syndrome in children. Neurol Sci 32(3):381\u2013385","journal-title":"Neurol Sci"},{"issue":"2","key":"5562_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pediatrneurol.2012.05.011","volume":"47","author":"J-J Lin","year":"2012","unstructured":"Lin J-J et al (2012) Clinical variants of Guillain-Barr\u00e9 syndrome in children. Pediatr Neurol 47(2):91\u201396","journal-title":"Pediatr Neurol"},{"issue":"3","key":"5562_CR31","first-page":"158","volume":"23","author":"R Koul","year":"2008","unstructured":"Koul R et al (2008) Clinical characteristics of childhood guillain-barr\u00e9 syndrome. Oman Med J 23(3):158","journal-title":"Oman Med J"},{"issue":"4","key":"5562_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1586\/1744666X.2016.1128829","volume":"12","author":"Y Wang","year":"2016","unstructured":"Wang Y et al (2016) Complications of Guillain-Barr\u00e9 syndrome. Expert Rev Clin Immunol 12(4):439\u2013448","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"5562_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","volume":"13","author":"J-E Kim","year":"2017","unstructured":"Kim J-E et al (2017) Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol (Seoul, Korea) 13(3):227","journal-title":"J Clin Neurol (Seoul, Korea)"},{"issue":"11","key":"5562_CR34","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s10072-020-04693-y","volume":"41","author":"K Rahimi","year":"2020","unstructured":"Rahimi K (2020) Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci 41(11):3149\u20133156","journal-title":"Neurol Sci"},{"key":"5562_CR35","doi-asserted-by":"crossref","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M (2021) Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol 268(4):1133\u20131170","DOI":"10.1007\/s00415-020-10124-x"},{"key":"5562_CR36","doi-asserted-by":"crossref","unstructured":"Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Ferrarese C (2020) Guillain-Barr\u00e9 syndrome related to COVID-19 infection. Neurol-Neuroimmunol Neuroinflam 7(4)","DOI":"10.1212\/NXI.0000000000000741"},{"issue":"4","key":"5562_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","volume":"62","author":"JB Caress","year":"2020","unstructured":"Caress JB et al (2020) COVID-19\u2013associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve 62(4):485\u2013491","journal-title":"Muscle Nerve"},{"key":"5562_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233\u2013235","journal-title":"J Clin Neurosci"},{"issue":"10","key":"5562_CR39","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/jnnp-2020-324491","volume":"91","author":"A Uncini","year":"2020","unstructured":"Uncini A, Vallat J-M, Jacobs BC (2020) Guillain-Barr\u00e9 syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J Neurol Neurosurg Psychiatry 91(10):1105\u20131110","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"5562_CR40","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","volume":"292","author":"P Haber","year":"2004","unstructured":"Haber P et al (2004) Guillain-Barr\u00e9 syndrome following influenza vaccination. JAMA 292(20):2478\u20132481","journal-title":"JAMA"},{"issue":"27","key":"5562_CR41","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP et al (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603\u20132615","journal-title":"N Engl J Med"},{"key":"5562_CR42","doi-asserted-by":"crossref","unstructured":"Oliver SE (2020) The advisory committee on immunization practices\u2019 interim recommendation for use of moderna COVID-19 vaccine\u2014United States, December\u00a02020. MMWR. Morbid Mortal Week Rep 69","DOI":"10.15585\/mmwr.mm6950e2"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05562-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05562-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05562-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:28:49Z","timestamp":1744190929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05562-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5562"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05562-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We received ethical exemption status from the Research Ethics Committee of Guilan University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In this study, we collected data of the patient with Guilain barre disease from their profile stored in the two referral\u00a0hospitals\u2019 data bank archives. To achieve this data, we got authorization access to this data directly from the\u00a0hospital\u2019s Chief executive officer(CEO). In this case, we got permission to use patients\u2019 medical history and\u00a0demographic information without revealing their names and personal information. Besides that, we surveyed the\u00a0prevalence of GBS for the past ten years, so our research has not had any effect on patients\u2019 diagnosis and\u00a0treatment. Also, our study was accepted in the Neuroscience Research Center of the Poursina Hospital of the\u00a0Guilan University of Medical Sciences and approved by the Research Ethics Committee of the Guilan University of\u00a0Medical Sciences (Code: IR.GUMS.REC.1398.340).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}